SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001640455-20-000089
Filing Date
2020-07-02
Accepted
2020-07-02 19:35:40
Documents
1
Period of Report
2020-06-26

Document Format Files

Seq Description Document Type Size
1 FORM 4/A wf-form4a_159373292481119.html 4/A  
1 FORM 4/A wf-form4a_159373292481119.xml 4/A 4537
  Complete submission text file 0001640455-20-000089.txt   5877
Mailing Address C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address
KARSEN PERRY A (Reporting) CIK: 0001260573 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-37998 | Film No.: 201011638

Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 857-259-3840
Jounce Therapeutics, Inc. (Issuer) CIK: 0001640455 (see all company filings)

IRS No.: 454870634 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)